Ondine Biomedical Inc. OBIMF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.84M | -5.89M | -6.08M | -6.16M | -4.54M |
| Total Depreciation and Amortization | 103.70K | 104.60K | 100.40K | 101.60K | 112.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 434.60K | 438.50K | 313.50K | 317.30K | 147.80K |
| Change in Net Operating Assets | 487.70K | 492.10K | 764.60K | 774.00K | 601.70K |
| Cash from Operations | -4.81M | -4.85M | -4.90M | -4.96M | -3.68M |
| Capital Expenditure | -40.80K | -41.20K | -33.40K | -33.80K | -8.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -40.80K | -41.20K | -33.40K | -33.80K | -8.70K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -78.00K | -78.00K | -81.00K | -81.00K | -109.00K |
| Issuance of Common Stock | 4.56M | 4.56M | 10.11M | 10.11M | 2.89M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -352.00K | -352.00K | -680.50K | -680.50K | -11.00K |
| Cash from Financing | 2.99M | 3.01M | 6.70M | 6.78M | 2.00M |
| Foreign Exchange rate Adjustments | -28.50K | -28.80K | 27.30K | 27.60K | 112.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.89M | -1.91M | 1.79M | 1.81M | -1.57M |